CNR Institutional Research Information System

POCHETTI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.611
NA - Nord America 1.266
SA - Sud America 338
EU - Europa 312
Continente sconosciuto - Info sul continente non disponibili 37
AF - Africa 28
OC - Oceania 2
Totale 3.594
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.202
SG - Singapore 682
CN - Cina 344
BR - Brasile 261
VN - Vietnam 181
HK - Hong Kong 166
FR - Francia 92
KR - Corea 77
IT - Italia 64
NL - Olanda 36
BD - Bangladesh 33
AR - Argentina 28
GB - Regno Unito 28
CA - Canada 27
IN - India 27
FI - Finlandia 25
ID - Indonesia 22
DE - Germania 18
JP - Giappone 18
EC - Ecuador 14
CO - Colombia 13
MX - Messico 12
IQ - Iraq 10
VE - Venezuela 10
PL - Polonia 7
TR - Turchia 7
ZA - Sudafrica 7
CR - Costa Rica 6
EG - Egitto 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
MY - Malesia 5
PT - Portogallo 5
AT - Austria 4
CL - Cile 4
HN - Honduras 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
PH - Filippine 4
PK - Pakistan 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
UA - Ucraina 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
PE - Perù 3
SE - Svezia 3
CZ - Repubblica Ceca 2
ES - Italia 2
GT - Guatemala 2
KG - Kirghizistan 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 3.558
Salva come PNG Salva come JPEG
Città #
Santa Clara 480
Singapore 406
Hefei 163
Hong Kong 160
San Jose 99
Lauterbourg 80
Seoul 77
Ashburn 73
Ho Chi Minh City 64
Beijing 53
Hanoi 53
Los Angeles 29
Chicago 21
São Paulo 20
Dallas 15
New York 13
Buffalo 12
Da Nang 12
Council Bluffs 11
Helsinki 11
Rio de Janeiro 9
Tokyo 9
Bogotá 8
Frankfurt am Main 8
Milan 8
Turku 8
Minamishinagawa 7
Newark 7
Rome 7
Atlanta 6
Belo Horizonte 6
Haiphong 6
Lappeenranta 6
Las Vegas 6
Tampa 6
Brooklyn 5
Chennai 5
Guayaquil 5
Houston 5
Manchester 5
Minneapolis 5
Mumbai 5
Quito 5
Warsaw 5
Blumenau 4
Brasília 4
Buenos Aires 4
Campinas 4
Curitiba 4
Greenville 4
Johannesburg 4
London 4
Montreal 4
Nairobi 4
Ninh Bình 4
Orem 4
Philadelphia 4
San José 4
The Bronx 4
Thái Bình 4
Amsterdam 3
Biên Hòa 3
Bom Despacho 3
Boston 3
Caxias do Sul 3
Corrientes 3
Covington 3
Delhi 3
Dhaka 3
Dubai 3
Düsseldorf 3
Fort Lauderdale 3
Fortaleza 3
Greenwood 3
Guarulhos 3
Hamilton 3
Hortolândia 3
Hải Dương 3
Jakarta 3
Joinville 3
Juiz de Fora 3
Lima 3
Maceió 3
Manaus 3
Maynard 3
Medellín 3
Memphis 3
Mexico City 3
Middletown 3
Modena 3
Poplar 3
Porto Alegre 3
Princeton 3
Queens 3
Raleigh 3
Sacramento 3
San Antonio 3
Sewell 3
Shanghai 3
Stockholm 3
Totale 2.188
Salva come PNG Salva come JPEG
Nome #
Resveratrol and Its Metabolites Bind to PPARs 105
Insights into PPARgamma Phosphorylation and Its Inhibition Mechanism 103
Pha-680626 is an effective inhibitor of the interaction between aurora-a and n-myc 88
Regulation of gene expression in the liver and adipose tissue by a new dual PPARalpha/gamma agonist 74
On the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands. 72
Discovery of novel chemical series of oxa-48 beta-lactamase inhibitors by high-throughput screening 72
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination 72
Crystal Structures of the Complexes between PPARgamma and two new ligands with dual activity 71
Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex 71
Screening of saponins and sapogenins from Medicago species as potential PPAR? agonists and X-ray structure of the complex PPAR?/caulophyllogenin 71
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy 69
Conformational studies of synthetic leucinostatin A fragments 68
Water induced beta-turn modification in a chemotactic tetrapeptide. Synthesis, crystal conformation, and activity of HCO-Met-Leu-DeltaZPhe-Phe-OMe 62
Structural basis of the transactivation deficiency of the human PPAR gamma F360L mutant associated with familial partial lipodystrophy 59
On the Metabolically Active Form of Metaglidasen: Improved Synthesis and Investigation of Its Peculiar Activity on Peroxisome Proliferator-Activated Receptors and Skeletal Muscles. 59
Conformationally constrained analogues of endogenous tripeptide inhibitors of zinc metalloproteinases. 58
A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor gamma Binding Properties and Biological Activities 58
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 57
Betulinic acid is a PPARg antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis 57
Structural Insight into Peroxisome Proliferator-Activated Receptor ³ Binding of Two Ureidofibrate-Like Enantiomers by Molecular Dynamics, Cofactor Interaction Analysis, and Site-Directed Mutagenesis 56
Design and biophysical characterization of atrazine-sensing peptides mimicking the Chlamydomonas reinhardtii plastoquinone binding niche. 52
Identification of the first PPARa/g able to bind to canonical and alternate sites of PPARg and to inhibit its Cdk-5-mediated phosphorylation 52
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode. 52
New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists able ti up regulate the mitochondrial carnitine shuttle system gene expression. 51
Metalloproteinase Inhibitors, their Therapeutic Use and Process for the Production of the Starting Compound in the Synthesis Thereof 51
LT175 is a novel PPARalpha/gamma ligand with potent insulin-sensitizing effects and reduced adipogenic properties 50
Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors alpha and gamma for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection 48
Inhibitors of Metalloproteinase, their Therapeutic Use, and Process for the Production of the Starting Compound in the Synthesis 46
Crystal Structure of PPARgamma Ligand Binding Domain complexed with a novel Partial Agonist: a new region of the hydrophobic pocket could be exploited for drug design 46
Affinity-Based Separation Methods for the Study of Biological Interactions: the case of Peroxisome Proliferator-Activated Receptors in drug discovery 40
The monoclinic phase of the 2/1 inclusion compound between deoxycholic acid and o-xylene 40
Crystal structure of the PPAR-gamma ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design 39
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8. 36
2 Angstrom X-ray structure of adamalysin II complexed with a peptide phosphonate inhibitor adopting a retro-binding mode 35
Peptides containing the sulfonamide junction: synthesis, structure, and conformation of Z-Tau-Pro-Phe-NHiPr 35
Structure of a triclinic phase of sodium dodecyl sulfate monohydrate. A comparison with other sodium dodecyl sulfate crystal phases 35
Frontal affinity chromatography with MS detection of the ligand binding domain of PPARg receptor: Ligand affinity screening and stereoselective ligand-macromolecule interaction. 34
Structure of the 4:1 inclusion compound between deoxycholic acid and (E)-p-dimethylaminobenzene 34
Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands. 34
Gamma-Turn Conformation Induced by ,-Disubstituted Amino Acids with a Cyclic Six-Membered Side Chain 33
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. 33
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 32
Structure and conformation of peptides containing the sulphonamide junction. I. N-acetyl-tauryl-L-phenylalanine methyl ester. 32
Computational study of the catalytic domain of human neutrophil collagenase. Specific role of the S3 and S3' subsites in the interaction with a phosphonate inhibitor 32
SYNTHESIS, Characterization and biological evaluation of ureidofibrate-like derivatives endowed with Peroxisome Proliferator-Activated Receptor Activity 32
Structural studies of a human chimeric plasminogen activator Amediplase (k2tu-PA) 32
New 2-Aryloxy-3-phenyl-propanoic Acids As Peroxisome Proliferator-Activated Receptors alpha/gamma Dual Agonists with Improved Potency and Reduced Adverse Effects on skeletal muscle function 31
Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor-gamma ligand-binding domain in the complex with two enantiomeric ligands 31
Identification of novel dual peroxisome proliferator-activated receptor alpha/gamma ligands and characterization of their biochemical properties by 3D structural studies 31
Internal .beta.-Turn Hydration: Crystallographic Evidence and Molecular Dynamics Simulation 31
Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides. 31
Topographically constrained aromatic-alpha-aza-amino acids. Synthesis, molecular structure, and conformation of two azaTic derivatives 30
Structure and conformation of peptides containing the sulphonamide junction. IV. Synthesis and crystal conformation of N-benzoyl-L-Phenylalanyl-Tauryl-L-Leucine Methyl Ester 30
Modified chemotactic peptides: synthesis, conformation, and biological activity of For-Thp-Leu-delta ZPhe-OMe. 29
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 28
Molecular organization of sodium dodecylsulfate in crystal phases 27
A reinvestigation of the reaction of N-(2-bromoethyl)isatoic anhydride with methyl amine. Isolation and crystal structure of 1-(2-hydroxyethyl)-3-methyl-2,4-(1H,3H)-Quinazolinedione 27
Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: implications for drug design. 27
Structural studies of Leucinostatin A and its Boc-Aib-Leu-Leu-Aib-OMe tetra peptide fragment 27
Studies on the activity of a new ligand of the peroxisome proliferator-activated receptors (PPARs) 27
Crystal structure, conformation, and potential energy calculations of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OMe. 27
Partial agonism in PPARs: the role of helix 3 26
Improved lipid metabolism and reduced fat deposition in a mouse model of diet-induced obesity (DIO) with a new dual PPARalpha/gamma ligand 26
Structure and conformation of peptides containing the sulphonamide junction. III. Synthesis, crystal and molecular structure of a taurine containing peptidic oxa-cyclol. 26
The inclusion compound of deoxycholic acid with (-)-camphor: a structural and energetic study 26
Retrosulfonamido peptide analogues. Synthesis and crystal conformation of Boc-Pro-Leu-psi(NH-SO2)-Gly-NH2 26
N-Acyl-diketopiperazines. II. Crystal structure and conformation of N-(pyruvoyl)-cyclo-(L-Phenylalanyl-D-Prolyl) 26
For-Met-DeltazLeu-Phe-OMe: A new active analog of chemotactic N-formyltripeptides with beta-turn crystal conformation 26
Stereoselectivity by enantiomeric inhibitors of matrix metalloproteinase-8: new insights from molecular dynamics simulations 26
On the mechanism of partial agonism: crystal structures of the peroxisome proliferators-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands 26
Overexpression system and biochemical profile of CTX-M-3 extended-spectrum beta-lactamase expressed in Escherichia coli. 26
Structural studies of chemotactic oligopeptides. Crystal, molecular structure and energy calculations of N-Formyl-Methionyl-Leucyl-Phenylalanyl methyl ester 25
The structure of 2/1 'Channel' Inclusion Compound between Deoxycholic Acid and Pinacolone, 2C24H40O4.C6H12O 25
Prochiral selectivity in H2O2-promoted oxidation of arylalkanols catalysed by chloroperoxidase 25
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue 25
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe. 25
Crystal phases obtained from aqueous solutions of sodium dodecyl sulfate. The structure of a monoclinic phase of sodium dodecyl sulfate hemihydrate 24
Novel dual PPARalpha/gamma agonists, as potential hypoglycemic and anti diabetic agents 24
Structural modification and conformational features of chemotactic N-formylpeptides 24
Structural insight into the crucial role of ligand chirality in the activation of PPARs by crystallographic methods 24
New chemotactic peptide analogs with high biological activity for human neutrophils. 24
Phosphonate inhibitors of adamalysin II and matrix metalloproteinases. 24
Synthesis and structural studies of N-p-Toluensulfonyl cyclodipeptides 23
Inhibition of Adamalysin II and MMPs by phosphonate analogues of snake venom peptides 23
Potential energy calculations on phenylalanine rotamers in different boat forms of proline-containing cyclic dipeptides. 22
Endoannular reactions and ring-chain tautomerism. Structure of 1-(2-Hydroxyethyl)-3-methyl-2,4(1H,3H)-quinazolinedione 22
Studies related to cephalosporins. 6(1). Bromination of 3-exomethylene in cepham derivatives 22
Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues. 21
Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe. 21
Structure and conformation of peptides containing the sulfonamide junction. II. Synthesis and conformation of cyclo[-MeTau-Phe-DPro-]. 20
Synthesis and properties of chemotactic peptide analogs. I. Crystal structure and molecular conformation of HCO-Met-leu-Ain-OMe. 19
Totale 3.594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.099
article - articoli 10.085
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.184
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20247 0 0 0 0 0 0 0 0 2 0 2 3
2024/20251.295 1 8 78 62 382 107 15 30 38 47 283 244
2025/20261.836 118 179 254 296 319 31 285 101 92 72 38 51
2026/2027456 129 110 217 0 0 0 0 0 0 0 0 0
Totale 3.594